Concurrent inhibition of CDK2 adds to the anti-tumour activity of CDK4/6 inhibition in GIST

被引：0
|
作者：
Inga-Marie Schaefer
Matthew L. Hemming
Meijun Z. Lundberg
Matthew P. Serrata
Isabel Goldaracena
Ninning Liu
Peng Yin
Joao A. Paulo
Steven P. Gygi
Suzanne George
Jeffrey A. Morgan
Monica M. Bertagnolli
Ewa T. Sicinska
Chen Chu
Shanshan Zheng
Adrian Mariño-Enríquez
Jason L. Hornick
Chandrajit P. Raut
Wen-Bin Ou
George D. Demetri
Sinem K. Saka
Jonathan A. Fletcher
机构：
[1] Harvard Medical School,Department of Pathology, Brigham and Women’s Hospital
[2] Dana-Farber Cancer Institute and Harvard Medical School,Department of Medical Oncology
[3] Dana-Farber Cancer Institute and Brigham and Women’s Hospital,Sarcoma Center
[4] Harvard University,Wyss Institute for Biologically Inspired Engineering
[5] Harvard Medical School,Department of Cell Biology
[6] Brigham and Women’s Hospital,Department of Surgery
[7] Harvard Medical School,Department of Pathology
[8] Dana-Farber Cancer Institute,Department of Cancer Biology
[9] Harvard Medical School,Department of Genetics
[10] Dana-Farber Cancer Institute,Zhejiang Provincial Key Laboratory of Silkworm Bioreactor and Biomedicine, College of Life Sciences and Medicine
[11] Blavatnik Institute,Ludwig Center at Harvard
[12] Harvard Medical School,European Molecular Biology Laboratory (EMBL)
[13] Zhejiang Sci-Tech University,undefined
[14] Harvard Medical School,undefined
[15] Genome Biology Unit,undefined
来源：
British Journal of Cancer | 2022年 / 127卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2072 / 2085
页数：13
相关论文
共 50 条
  • [31] Preclinical evaluation of CDK4 phosphorylation predicts high sensitivity of pleural mesotheliomas to CDK4/6 inhibition
    Paternot, Sabine
    Raspe, Eric
    Meiller, Clement
    Tarabichi, Maxime
    Assie, Jean-Baptiste
    Libert, Frederick
    Remmelink, Myriam
    Bisteau, Xavier
    Pauwels, Patrick
    Blum, Yuna
    Le Stang, Nolwenn
    Tabone-Eglinger, Severine
    Galateau-Salle, Francoise
    Blanquart, Christophe
    Van Meerbeeck, Jan P.
    Berghmans, Thierry
    Jean, Didier
    Roger, Pierre P.
    MOLECULAR ONCOLOGY, 2024, 18 (04) : 866 - 894
  • [32] Study of a ligand complexed with Cdk2/Cdk4 by computer simulation
    Yongjun Jiang
    Jianwei Zou
    Chunshan Gui
    Journal of Molecular Modeling, 2005, 11 : 509 - 515
  • [33] Slower CDK4 and faster CDK2 activation in the cell cycle
    Zhang, Wengang
    Liu, Yonglan
    Jang, Hyunbum
    Nussinov, Ruth
    STRUCTURE, 2024, 32 (08)
  • [34] Targeting the cell cycle - Beyond CDK4/6 inhibition
    Jeselsohn, R.
    CANCER RESEARCH, 2020, 80 (04)
  • [35] Mechanisms of therapeutic CDK4/6 inhibition in breast cancer
    Scott, Susan Combs
    Lee, Sarah S.
    Abraham, Jame
    SEMINARS IN ONCOLOGY, 2017, 44 (06) : 385 - 394
  • [36] CDK4/6 inhibition triggers an antitumor immune response
    DeCristo, Molly J.
    Goel, Shom
    Watt, April C.
    BrinJones, Haley
    Sceneay, Jaclyn
    Li, Ben B.
    Khan, Naveed
    Ubellacker, Jessalyn M.
    Xie, Shaozhen
    Metzger-Filho, Otto
    Hoog, Jeremy
    Ellis, Matthew J.
    Ma, Cynthia
    Ramm, Susanne
    Krop, Ian E.
    Winer, Eric P.
    Roberts, Thomas M.
    Kim, Hye-Jung
    Zhao, Jean J.
    McAllister, Sandra S.
    CANCER IMMUNOLOGY RESEARCH, 2018, 6 (09)
  • [37] Study of a ligand complexed with Cdk2/Cdk4 by computer simulation
    Jiang, YJ
    Zou, JW
    Gui, CS
    JOURNAL OF MOLECULAR MODELING, 2005, 11 (06) : 509 - 515
  • [38] CDK4/6 inhibition: the late harvest cycle begins
    Goel, Shom
    Zhao, Jean J.
    ONCOTARGET, 2016, 7 (31) : 48854 - 48856
  • [39] Inhibition of Mitochondrial Antioxidant Defense and CDK4/6 in Mesothelioma
    Kratzke, Marian
    Scaria, George
    Porter, Stephen
    Kren, Betsy
    Klein, Mark A.
    MOLECULES, 2023, 28 (11):
  • [40] Inhibition of CDK4/6 as a novel therapeutic option for neuroblastoma
    Ali Rihani
    Jo Vandesompele
    Frank Speleman
    Tom Van Maerken
    Cancer Cell International, 15
12345